The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021

JurisdictionUK Non-devolved
CitationSI 2021/26
Year2021

2021 No. 26

Health Care And Associated ProfessionsPharmacy

The General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021

Made 12th January 2021

Laid before Parliament 14th January 2021

Coming into force 4th March 2021

At the Council Chamber, Whitehall, the 12th day of January 2021

By the Lords of Her Majesty’s Most Honourable Privy Council

The General Pharmaceutical Council has made the General Pharmaceutical Council (Coronavirus) (Amendment) Rules 2021, which are set out in the Schedule to this Order, in exercise of the powers conferred by articles 19(3), 61(1), (2)(a), (3)(a) and (6)(b), 66(1) of, and paragraph 5(1)(a) and (d) of Schedule 1 to, the Pharmacy Order 20101.

In accordance with article 66(3) of that Order, the General Pharmaceutical Council has consulted such persons or organisations as it considered appropriate.

By virtue of article 66(4) of that Order, such rules cannot come into force until approved by order of the Privy Council.

S-1 Citation and commencement

Citation and commencement

1. This Order may be cited as the General Pharmaceutical Council (Coronavirus) (Amendment) Rules Order of Council 2021 and comes into force on 4th March 2021.

S-2 Privy Council Approval

Privy Council Approval

2. Their Lordships, having taken the Rules as set out in the Schedule to this Order into consideration, are pleased to, and do, approve them.

Richard Tillbrook

Clerk of the Privy Council

SCHEDULE

Article 2

The General Pharmaceutical Council (Coronavirus) (Amendment) Rules 2021

The General Pharmaceutical Council makes these Rules, in exercise of the powers conferred by articles 19(3), 61(1), (2)(a), (3)(a) and (6)(b), 66(1) of, and paragraph 5(1)(a) and (d) of Schedule 1 to, the Pharmacy Order 20102.

In accordance with article 66(3) of that Order, the General Pharmaceutical Council has consulted such persons or organisations as it considered appropriate.

SCH-1.1

1. Citation and commencement

(1) These Rules may be cited as the General Pharmaceutical Council (Coronavirus) (Amendment) Rules 2021 and come into force on 4th March 2021.

(2) Subject to paragraph (3), at the end of 1st May 2021—

(a)

(a) the amendments made by these Rules expire, and

(b)

(b) the provisions amended by these Rules, as they were in force immediately prior to the amendments made by these Rules, are revived.

(3) Rule 1(2) does not apply to the amendments made by rules 2(4), 3(4) and 5.

SCH-1.2

2. Amendment of the General Pharmaceutical Council (Appeals Committee) Rules 2010

(1) The General Pharmaceutical Council (Appeals Committee) Rules 20103are amended as follows.

(2) In rule 2 (Interpretation), after the definition of “appellant” insert—

““attend” means—

(a) be physically present at a meeting or hearing, or

(b) be present at a meeting or hearing by teleconference or video link;”.

(3) After rule 2, insert—

SCH-1.2A

Virtual meetings and hearings

2A. Meetings or hearings arranged under these Rules may be conducted by teleconference or video link.”.

(4) In rule 3(2) (Service of documents)—

(a)

(a) for the words before “by electronic mail”, substitute “Notices or documents may be sent to a person under these Rules”, and

(b)

(b) for “secretary”, substitute “Council”.

(5) In rule 6 (Notice of Hearing) for (a) substitute—

“(a)

“(a) state—

(i) the date, time and venue of the hearing, or

(ii) if the hearing is to be conducted by teleconference or video link, the date and time of, and instructions on how to access, the hearing;”.

(6) In rule 12(2) (Procedure at hearings)—

(a)

(a) in sub-paragraph (b), after “present” insert “(either physically or by teleconference or video link)”;

(b)

(b) in sub-paragraph (h), after “present” insert “, either physically or by teleconference or video link”.

(7) After rule 16(4) (Attendance of the public at hearings), insert —

SCH-1.5

“5 Where a hearing is being held by teleconference or video link, the Committee may order that the hearing is to be held in private.”.

SCH-1.3

3. Amendment of the General Pharmaceutical Council (Fitness to Practise and Disqualification etc.) Rules 2010

(1) The General Pharmaceutical Council (Fitness to Practise and Disqualification etc.) Rules 20104are amended as follows.

(2) In rule 2 (Interpretation), after the definition of “applicant concerned” insert—

““attend” means—

(a) be physically present at a meeting or hearing, or

(b) be present at a meeting or hearing by teleconference or video link;”.

(3) After rule 2, insert—

SCH-1.2A

Virtual meetings and hearings

2A. Meetings and hearings arranged under these rules may be conducted by teleconference or video link.”.

(4) In rule 3(1) (Service of documents), omit “, with the agreement of the person concerned,”.

(5) In rule 16 (Notices of hearing other than interim order hearings) for rule (2)(a) substitute—

“(a)

“(a) state—

(i) the date, time and venue of the hearing, or

(ii) if the hearing is to be conducted by teleconference or video link, the date and time of, and instructions on how to access, the hearing;”.

(6) In rule 17 (Interim Order Notices and court referrals), for rule (2)(a) substitute—

“(a)

“(a)...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT